On September 30, 2024, Todd Harris, President and Chief Executive Officer of Tyra Biosciences Inc (TYRA, Financial), sold 500 shares of the company. The transaction was documented in an SEC Filing. Following this sale, the insider now owns 1,477,373 shares of Tyra Biosciences Inc.
Tyra Biosciences Inc is a biotechnology firm focused on developing precision medicines for patients with genetically defined cancers. The company leverages its proprietary SNÃ…P platform to rapidly and precisely validate genetically defined targets and advance a pipeline of novel drug candidates.
Over the past year, Todd Harris has sold a total of 128,554 shares and has not made any purchases of the company's stock. This recent sale is part of a broader trend observed within the company, where there have been 12 insider sells and no insider buys over the past year.
Shares of Tyra Biosciences Inc were trading at $24 on the day of the sale, giving the company a market cap of approximately $1.18 billion.
This insider activity comes at a time when the stock's valuation metrics, such as GF Value, price-earnings ratio, price-sales ratio, price-book ratio, and price-to-free cash flow are being closely monitored by investors.
The insider's ongoing transactions provide valuable insights into the company's internal perspective on its stock's value and future prospects.
This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.
